Next-Generation Fighter Jets?!? (Must See)
The U.S. Department of Defense is using one shocking company to develop breakthrough tech...And at less than $2... this could be the last bargain on the market.

Get the Details Here (Act Fast... a Key Announcement in December Could Send It Rocketing)
>>>
pixel
Nicola Heffron net worth and biography

Nicola Heffron Biography and Net Worth

COO of 2seventy bio
Nicola Heffron is chief operating officer at 2seventy bio. Previously, Nicola was at bluebird bio for almost two years, where she held multiple leadership positions, most recently as chief operating officer of the oncology business unit. She has accumulated over 25 years of experience across R&D, global commercial, and local operational P&L and marketing strategy roles. She led the commercial launch for a global franchise across 16 rare and specialty brands. Most recently Nicola led the Global Myeloid Commercial team at Celgene. Before this, she ran the Global Internal Medicine Franchise for Shire and held a number of leadership roles in R&D and Commercial at global, regional, and affiliate levels at GSK and Eli Lilly. A qualified pharmacist, Nicola holds an M.B.A. from the University of Warwick in the UK.

What is Nicola Heffron's net worth?

The estimated net worth of Nicola Heffron is at least $1.45 million as of November 21st, 2022. Ms. Heffron owns 90,226 shares of 2seventy bio stock worth more than $1,447,225 as of December 5th. This net worth approximation does not reflect any other investments that Ms. Heffron may own. Additionally, Ms. Heffron receives an annual salary of $2,470,000.00 as COO at 2seventy bio. Learn More about Nicola Heffron's net worth.

How old is Nicola Heffron?

Ms. Heffron is currently 49 years old. There are 3 older executives and no younger executives at 2seventy bio. Learn More on Nicola Heffron's age.

What is Nicola Heffron's salary?

As the COO of 2seventy bio, Inc., Ms. Heffron earns $2,470,000.00 per year. Learn More on Nicola Heffron's salary.

How do I contact Nicola Heffron?

The corporate mailing address for Ms. Heffron and other 2seventy bio executives is , , . 2seventy bio can also be reached via phone at 339-499-9300 and via email at [email protected] Learn More on Nicola Heffron's contact information.

Has Nicola Heffron been buying or selling shares of 2seventy bio?

In the last ninety days, Nicola Heffron has sold $107,527.09 in shares of 2seventy bio stock. Most recently, Nicola Heffron sold 7,697 shares of the business's stock in a transaction on Monday, November 21st. The shares were sold at an average price of $13.97, for a transaction totalling $107,527.09. Following the completion of the sale, the chief operating officer now directly owns 90,226 shares of the company's stock, valued at $1,260,457.22. Learn More on Nicola Heffron's trading history.

Who are 2seventy bio's active insiders?

2seventy bio's insider roster includes William Baird, III (CFO), Philip Gregory (Insider), Nicola Heffron (COO), and Nick Leschly (CEO). Learn More on 2seventy bio's active insiders.

Are insiders buying or selling shares of 2seventy bio?

During the last twelve months, insiders at the sold shares 13 times. They sold a total of 39,582 shares worth more than $642,560.75. The most recent insider tranaction occured on November, 21st when COO Nicola Heffron sold 7,697 shares worth more than $107,527.09. Insiders at 2seventy bio own 2.5 % of the company. Learn More about insider trades at 2seventy bio.

Information on this page was last updated on 11/21/2022.

Nicola Heffron Insider Trading History at 2seventy bio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/21/2022Sell7,697$13.97$107,527.0990,226View SEC Filing Icon  
2/7/2022Sell1,636$16.01$26,192.36View SEC Filing Icon  
2/4/2022Sell467$15.41$7,196.47View SEC Filing Icon  
12/7/2021Sell257$31.06$7,982.42View SEC Filing Icon  
See Full Table

Nicola Heffron Buying and Selling Activity at 2seventy bio

This chart shows Nicola Heffron's buying and selling at 2seventy bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

2seventy bio Company Overview

2seventy bio logo
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Read More

Today's Range

Now: $16.04
Low: $14.83
High: $16.17

50 Day Range

MA: $15.19
Low: $12.87
High: $17.00

2 Week Range

Now: $16.04
Low: $9.91
High: $34.02

Volume

312,600 shs

Average Volume

444,310 shs

Market Capitalization

$608.19 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Next-Generation Fighter Jets?!? (Must See)
The U.S. Department of Defense is using one shocking company to develop breakthrough tech...And at less than $2... this could be the last bargain on the market.

Get the Details Here (Act Fast... a Key Announcement in December Could Send It Rocketing)
>>>
pixel